I am the Principal Investigator for POW Hospital for the DECIDE study.
DECIDE study: Dexmedetomidine in Cardiac surgical Intraoperative Drug Evaluation
The DECIDE study is a large (n=1,100) four year, triple blind, placebo-controlled, randomised trial evaluating whether dexmedetomidine (DEX) improves:
- Days alive and free of delirium and coma at 14 days
- Days alive and at home at 30 days
- 1-year cognitive outcomes after cardiac surgery
Principal investigator: Professor Robert Sanders, University of Sydney
I co-ordinate and manage the DECIDE trial on Randwick Clinical Campus